Micron Biomedical has raised over $16 million in Series A3 financing, bringing its total Series A equity raise to more than $33 million. The round was co-led by J2 Ventures and the Global Health Investment Corporation (GHIC) and will support the expansion of Micron’s commercial manufacturing capabilities. This funding marks a major step forward in scaling Micron’s needle-free technology for global impact.